DAPAFLOZIN GM1

Dapaflozin GM 1 Tablet is a comprehensive triple-combination antidiabetic medication formulated to help control blood sugar levels in adults with Type 2 Diabetes Mellitus. It combines three effective agents:

• Dapagliflozin 10 mg – an SGLT2 inhibitor that enhances glucose excretion through the urine.

• Glimepiride 1 mg – a sulfonylurea which stimulates insulin release from the pancreas.

• Metformin 500 mg – a biguanide that reduces hepatic glucose production and improves insulin sensitivity.

This synergistic combination supports robust glycemic control through diverse mechanisms, particularly valuable for patients needing intensified therapy.

Key Benefits:

• Comprehensive glycemic control: Targets fasting and post-meal blood sugar.

• Supports heart and kidney health: SGLT2 inhibitors offer cardiovascular and renal benefits.

• Convenient once-daily dosing: Enhances patient adherence.

• May aid in weight management due to mild calorie loss through urinary glucose.